The ESSENCE-Questionnaire for Neurodevelopmental Problems - A Swedish School-Based Validation Study in 11-Year-Old Children.
ESSENCE-Q
neurodevelopment
school
screening
Journal
Neuropsychiatric disease and treatment
ISSN: 1176-6328
Titre abrégé: Neuropsychiatr Dis Treat
Pays: New Zealand
ID NLM: 101240304
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
05
2022
accepted:
27
07
2022
entrez:
22
9
2022
pubmed:
23
9
2022
medline:
23
9
2022
Statut:
epublish
Résumé
To determine the prevalence of parent-rated developmental concern using the ESSENCE-Q (Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations-Questionnaire, 12-items, score range 0-24) and to ascertain the predictive validity and optimal cutoff level of the instrument in a school-based sample of 11-year-old children. In a cross-sectional, school-based study, participants underwent a clinical assessment by a physician and a psychologist, teachers and parents completed the SDQ (Strength and Difficulties Questionnaire), medical health records and national tests were reviewed, and parents independently completed the ESSENCE-Q. In a case-conference outcomes were defined as a) the need for further clinical work-up due to suspected neurodevelopmental problems (NDPs) and b) degree of investigator-rated symptoms/impairment from NDPs on the CGI-S (Clinical Global Impression-Severity instrument, range 1-7, 4-7 defined as clinically symptomatic). Classification and optimal cutoffs of the ESSENCE-Q were determined using ROC (Receiver Operating Characteristic) analysis. Out of 343 eligible children, 223 enrolled, of whom 173 (50% of all eligible) had a parent-rated ESSENCE-Q. At least one of the 12 possible concerns was reported by parents of 36% of participants. Overall, in 101 (57%) participants a work-up was warranted, and 64 (37%) were clinically symptomatic from NDPs. The AUC of the ESSENCE-Q in detecting need for work-up was 0.70 (95% confidence interval [CI] 0.63-0.77), and the AUC in detecting clinically symptomatic participants was 0.82 (95% CI 0.76-0.88). ESSENCE-Q ratings correlated positively with CGI-S scores ( This study of the ESSENCE-Q in 11-year-old children suggests it might be an acceptable instrument for screening of NDPs in children in middle school, optimally in conjunction with other methods.
Identifiants
pubmed: 36133028
doi: 10.2147/NDT.S374930
pii: 374930
pmc: PMC9484576
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2055-2067Informations de copyright
© 2022 Landgren et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Am J Psychiatry. 2021 Aug 1;178(8):752-760
pubmed: 33900814
J Child Psychol Psychiatry. 2018 Aug;59(8):863-871
pubmed: 29484650
JAMA Psychiatry. 2020 Feb 1;77(2):155-164
pubmed: 31746968
J Child Psychol Psychiatry. 2014 May;55(5):436-45
pubmed: 24274762
Acta Paediatr. 2006 Jun;95(6):664-70
pubmed: 16754546
Seizure. 2019 Oct;71:233-239
pubmed: 31425870
Eur Neuropsychopharmacol. 2013 Dec;23(12):1732-8
pubmed: 23953271
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
pubmed: 20526405
J Child Psychol Psychiatry. 2018 Jul;59(7):744-751
pubmed: 29377119
Res Dev Disabil. 2010 Nov-Dec;31(6):1543-51
pubmed: 20634041
Neuropsychiatr Dis Treat. 2018 Aug 23;14:2141-2148
pubmed: 30197517
Eur Child Adolesc Psychiatry. 1999 Jun;8(2):63-70
pubmed: 10435454
Child Adolesc Psychiatry Ment Health. 2013 Dec 10;7(1):40
pubmed: 24325882
J Child Psychol Psychiatry. 2014 Aug;55(8):897-904
pubmed: 24673585
Neuropsychiatr Dis Treat. 2016 Jul 14;12:1739-46
pubmed: 27478377
Int J Methods Psychiatr Res. 2018 Mar;27(1):
pubmed: 29024371
Dev Med Child Neurol. 1996 Oct;38(10):891-906
pubmed: 8870611
Lancet Psychiatry. 2017 Apr;4(4):339-346
pubmed: 27979720
Neuropsychiatr Dis Treat. 2017 May 10;13:1271-1280
pubmed: 28546752
Am J Psychiatry. 2022 Feb;179(2):142-151
pubmed: 34384227
Asian J Psychiatr. 2022 Jul;73:103162
pubmed: 35605519
JAMA Psychiatry. 2020 Sep 1;77(9):936-943
pubmed: 32374377
Acta Paediatr. 2004 Jul;93(7):976-81; discussion 872-3
pubmed: 15303816
Autism Res. 2019 Feb;12(2):176-199
pubmed: 30707000
J Am Acad Child Adolesc Psychiatry. 2022 Aug;61(8):982-996
pubmed: 34958872
Acta Paediatr. 2020 Apr;109(4):764-773
pubmed: 31545530
Eur Child Adolesc Psychiatry. 2003 Aug;12(4):162-71
pubmed: 14505066
Acta Paediatr. 2021 Jul;110(7):2134-2141
pubmed: 33686710